Profound Medical Corp

Price Chart

Risk-Adjusted Performance

Also Listed On

Profound Medical Corp (PRN) Price Performance

Profound Medical Corp (PRN) trades on Toronto Stock Exchange in CAD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at CAD9.34, up 2.41% from the previous close.

Over the past year, PRN has traded between a low of CAD5.35 and a high of CAD12.11. The stock has gained 20.2% over this period. It is currently 22.9% below its 52-week high.

Profound Medical Corp has a market capitalization of $323.01M.

About Profound Medical Corp

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.

Compare Profound Medical Corp

Side-by-side comparison against top Healthcare peers.